MA33958B1 - Pyrazine derivatives and their use in the treatment of neurological disorders - Google Patents

Pyrazine derivatives and their use in the treatment of neurological disorders

Info

Publication number
MA33958B1
MA33958B1 MA35108A MA35108A MA33958B1 MA 33958 B1 MA33958 B1 MA 33958B1 MA 35108 A MA35108 A MA 35108A MA 35108 A MA35108 A MA 35108A MA 33958 B1 MA33958 B1 MA 33958B1
Authority
MA
Morocco
Prior art keywords
treatment
neurological disorders
pyrazine derivatives
pyrazine
derivatives
Prior art date
Application number
MA35108A
Other languages
Arabic (ar)
French (fr)
Inventor
Carsten Bahl
Stefan Brosig
Viktor Enoekl
Dörte Laing
Michael Fiss
Marina Tintelnot-Blomley
Siem Jacob Veenstra
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102009060911A external-priority patent/DE102009060911A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/EP2010/070502 external-priority patent/WO2011080176A1/en
Publication of MA33958B1 publication Critical patent/MA33958B1/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
    • Y02E60/14—Thermal energy storage

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

يتعلق الاختراع بمركبات حلقية غير متجانسة جديدة ممثلة في الصيغة (i) ، حيث تم تعريف جميع المتغيرات في التحديد، في شكل حر أو في شكل ملح، بإعدادها، باستخدامها الطبي وبالأدوية التي تحتوي على هذه المركبات.The invention relates to new heterocyclic compounds represented in formula (i), where all variables in the determination, in free form or in salt form, are defined by their preparation, by their medical use, and by the drugs containing these compounds.

MA35108A 2009-12-31 2010-12-22 Pyrazine derivatives and their use in the treatment of neurological disorders MA33958B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29172409P 2009-12-31 2009-12-31
DE102009060911A DE102009060911A1 (en) 2009-12-31 2009-12-31 Device and system for temporary storage of thermal energy
PCT/EP2010/070502 WO2011080176A1 (en) 2009-12-31 2010-12-22 Pyrazine derivatives and their use in the treatment of neurological disorders

Publications (1)

Publication Number Publication Date
MA33958B1 true MA33958B1 (en) 2013-01-02

Family

ID=47520485

Family Applications (1)

Application Number Title Priority Date Filing Date
MA35108A MA33958B1 (en) 2009-12-31 2010-12-22 Pyrazine derivatives and their use in the treatment of neurological disorders

Country Status (1)

Country Link
MA (1) MA33958B1 (en)

Similar Documents

Publication Publication Date Title
EA201200952A1 (en) DERIVATIVES OF PYRAZINE AND THEIR APPLICATION FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
EA201200176A1 (en) OXAZIN DERIVATIVES AND THEIR APPLICATION FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
EA201391029A1 (en) OXAZIN DERIVATIVES AND THEIR APPLICATION IN THE TREATMENT OF NEUROLOGICAL DISORDERS
EA201200174A1 (en) OXAZIN DERIVATIVES AND THEIR APPLICATION AS BACE INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
EA201391106A1 (en) NEW HETEROCYCLIC DERIVATIVES
EA201391032A1 (en) NEW HETEROCYCLIC DERIVATIVES AND THEIR APPLICATION IN THE TREATMENT OF NEUROLOGICAL DISORDERS
EA201490888A1 (en) NEW PURIN DERIVATIVES AND THEIR APPLICATION FOR THE TREATMENT OF DISEASE
EA201200318A1 (en) Heterocyclic oximes
EA201400161A1 (en) SUBSTITUTED HETEROAROMATIC PYRAZOL-CONTAINING CARBOXAMIDE AND UTERIN DERIVATIVES AS VIANILLOID RECEPTOR LIGANDS
WO2012016186A8 (en) Macrocyclic kinase inhibitors and uses thereof
UA107188C2 (en) CARBOXAMID DERIVATIVES OF QUINASOLINES OR QUINOLINES AND PHARMACEUTICAL COMPOSITION THEREOF
DK2150530T3 (en) Substituted sulfonamide derivatives
EA201200260A1 (en) HETEROCYCLIC HYDRAZONES AND THEIR APPLICATION FOR THE TREATMENT OF CANCER AND INFLAMMATION
MX2013012652A (en) Derivatives of n- [(1h-pyrazol-1-yl) aryl] - 1h - indole or 1h - indazole - 3 - carboxamide, their preparation and their use as p2y12 antagonists.
PH12013500007A1 (en) Piperidine derivatives and their use for the treatment of metabolic disorders
MX2014000964A (en) Substituted heterocyclic aza derivatives.
MX2012007582A (en) 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds.
MA32723B1 (en) Anilino-pyrimidine derivatives substituted with sulfoximine marked as CDK inhibitors, their preparation and use as drugs
EA201490630A1 (en) 6-SUBSTITUTED 3- (QUINOLIN-6-ILTIO) [1,2,4] TRIAZOLO [4,3-A] Pyridine as inhibitors of C-MET THYROZINKINASE
MX2016007989A (en) Oxindole derivatives, preparation thereof and therapeutic use in the treatment of ampk-related diseases.
MX2013002208A (en) Sulfonylpiperazine derivatives that interact with glucokinase regulatory protein for the treatment of diabetes.
MX2014003455A (en) Aryl or n-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands.
MA33958B1 (en) Pyrazine derivatives and their use in the treatment of neurological disorders
MX2013011561A (en) Benzodioxepine and benzodioxine compounds that interact with glucokinase regulatory protein for the treatment of diabetes.
CA2863110A1 (en) 1,2- pyridazine, 1,6- pyridazine or pyrimidine - benzamide derivatives as gpbar1 modulators